Annuaire
Publications
This folder holds the following references to publications, sorted by year and author.
There are 64 references in this bibliography folder.
Planel, S, Salomon, A, Jalinot, P, Feige, J, and Cherradi, N
(2010).
A novel concept in antiangiogenic and antitumoral therapy: multitarget destabilization of short-lived mRNAs by the zinc finger protein ZFP36L1.
Oncogene, 29(45):5989-6003.
Terme, J, Lhermitte, L, Asnafi, V, and Jalinot, P
(2009).
TGF-beta induces degradation of TAL1/SCL by the ubiquitin-proteasome pathway through AKT-mediated phosphorylation.
Blood, 113(26):6695-8.
Terme, J, Mocquet, V, Kuhlmann, A, Zane, L, Mortreux, F, Wattel, E, Duc Dodon, M, and Jalinot, P
(2009).
Inhibition of the hTERT promoter by the proto-oncogenic protein TAL1.
Leukemia, 23(11):2081-9.
Wencker, M, Gazzolo, L, and Duc Dodon, M
(2009).
The leukemogenic activity of TaxHTLV-1 during human alphabeta T cell development.
Front Biosci (Schol Ed), 1:194-204.
Terme, J, Wencker, M, Favre-Bonvin, A, Bex, F, Gazzolo, L, Duc Dodon, M, and Jalinot, P
(2008).
Cross talk between expression of the human T-cell leukemia virus type 1 Tax transactivator and the oncogenic bHLH transcription factor TAL1.
J Virol, 82(16):7913-22.
Vitte, A and Jalinot, P
(2008).
Intracellular delivery of peptides via association with ubiquitin or SUMO-1 coupled to protein transduction domains.
BMC Biotechnol, 8:24.
Buchsbaum, S, Morris, C, Bochard, V, and Jalinot, P
(2007).
Human INT6 interacts with MCM7 and regulates its stability during S phase of the cell cycle.
Oncogene, 26(35):5132-44.
Kuhlmann, A, Villaudy, J, Gazzolo, L, Castellazzi, M, Mesnard, J, and Duc Dodon, M
(2007).
HTLV-1 HBZ cooperates with JunD to enhance transcription of the human telomerase reverse transcriptase gene (hTERT).
Retrovirology, 4:92.
Morris, C, Wittmann, J, Jack, H, and Jalinot, P
(2007).
Human INT6/eIF3e is required for nonsense-mediated mRNA decay.
EMBO Rep, 8(6):596-602.
Molle, V, Zanella-Cleon, I, Robin, J, Mallejac, S, Cozzone, AJ, and Becchi, M
(2006).
Characterization of the phosphorylation sites of Mycobacterium tuberculosis serine/threonine protein kinases, PknA, PknD, PknE, and PknH by mass spectrometry.
Proteomics, 6(13):3754-66.
Vitte, A, Buchsbaum, S, and Jalinot, P
(2006).
Modulation of HIV-1 Rev protein abundance and activity by polyubiquitination with unconventional Lys-33 branching.
FEBS Lett, 580(26):6155-60.
Favre-Bonvin, A, Reynaud, C, Kretz-Remy, C, and Jalinot, P
(2005).
Human papillomavirus type 18 E6 protein binds the cellular PDZ protein TIP-2/GIPC, which is involved in transforming growth factor beta signaling and triggers its degradation by the proteasome.
J Virol, 79(7):4229-37.
Morris, C and Jalinot, P
(2005).
Silencing of human Int-6 impairs mitosis progression and inhibits cyclin B-Cdk1 activation.
Oncogene, 24(7):1203-11.
Roisin, A, Robin, J, Dereuddre-Bosquet, N, Vitte, A, Dormont, D, Clayette, P, and Jalinot, P
(2004).
Inhibition of HIV-1 replication by cell-penetrating peptides binding Rev.
J Biol Chem, 279(10):9208-14.
Actions sur le document
